Anti-MyD88 antibody [EPR21824]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(76 Publications)
Anti-MyD88 antibody [EPR21824] (ab219413) is a rabbit monoclonal antibody detecting MyD88 in Western Blot, IP. Suitable for Human, Mouse, Rat.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 40 publications
View Alternative Names
Myeloid differentiation primary response protein MyD88, MYD88
- IP
Supplier Data
Immunoprecipitation - Anti-MyD88 antibody [EPR21824] (AB219413)
MyD88 was immunoprecipitated from 0.35 mg RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate with ab219413 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab219413 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/5000 dilution.
Lane 1 : RAW 264.7 whole cell lysate 10 μg (Input).
Lane 2 : ab219413 IP in RAW 264.7 whole cell lysate (+).
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab219413 in RAW 264.7 whole cell lysate (-).
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : 3 minutes.
All lanes:
Immunoprecipitation - Anti-MyD88 antibody [EPR21824] (ab219413)
Predicted band size: 33 kDa
false
- WB
Lab
Western blot - Anti-MyD88 antibody [EPR21824] (AB219413)
Blocking/Dilution buffer : 5% NFDM/TBST.
ab219413 was shown to specifically react with MyD88 in wild-type HAP1 cells as signal was lost in MyD88 knockout cells. Wild-type and MyD88 knockout samples were subjected to SDS-PAGE. ab219413 and ab181602 (Rabbit anti-GAPDH loading control) were incubated 1 hour at room temperature at 1/1000 dilution and 1/200,000 dilution respectively. Blots were developed with Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) secondary antibody at 1/100,000 dilution for 1 hour at room temperature before imaging. The blot was developed on a BIO-RAD® ChemiDoc™ MP instrument using the ECL technique
All lanes:
Western blot - Anti-MyD88 antibody [EPR21824] (ab219413) at 1/100000 dilution
Lane 1:
Wild-type HAP1 whole cell lysate at 20 µg
Lane 2:
MyD88 knockout HAP1 whole cell lysate at 20 µg
Lane 3:
HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 4:
Ramos (Human Burkitt's lymphoma B lymphocyte) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 33 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-MyD88 antibody [EPR21824] (AB219413)
False colour image of Western blot : Anti-MyD88 antibody [EPR21824] staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab219413 was shown to bind specifically to MyD88. A band was observed at 35 kDa in wild-type A549 cell lysates with no signal observed at this size in MYD88 knockout cell line ab286715 (knockout cell lysate ab290793). To generate this image, wild-type and MYD88 knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-MyD88 antibody [EPR21824] (ab219413) at 1/1000 dilution
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
MYD88 knockout A549 cell lysate at 20 µg
Lane 2:
Western blot - Human MYD88 knockout A549 cell line (<a href='/en-us/products/cell-lines/human-myd88-knockout-a549-cell-line-ab286715'>ab286715</a>)
Lane 3:
HEK-293 cell lysate at 20 µg
Secondary
Lanes 1 - 3:
Goat anti-Mouse IgG H&L 680RD
Lanes 1 - 3:
Goat anti-Rabbit IgG H&L 800CW
Predicted band size: 33 kDa
Observed band size: 35 kDa
false
- WB
Supplier Data
Western blot - Anti-MyD88 antibody [EPR21824] (AB219413)
Blocking/Dilution buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-MyD88 antibody [EPR21824] (ab219413) at 1/1000 dilution
Lane 1:
Rat liver lysate at 20 µg
Lane 2:
RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate at 20 µg
Lane 3:
A20 (Mouse reticulum sarcoma B lymphocyte) cell lysate at 20 µg
Lane 4:
Mouse liver lysate at 20 µg
Lane 5:
Mouse lung lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 33 kDa
false
Exposure time: 3min
Related conjugates and formulations (1)
-
Anti-MyD88 antibody [EPR21824] - BSA and Azide free
Reactivity data
Product details
What is this antibody validated in?
Anti-MyD88 antibody [EPR21824] (ab219413) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP) in Human, Mouse, Rat samples.
What is the molecular weight of MyD88?
Anti-MyD88 [EPR21824] (ab219413) specifically detects a band for MyD88 (UniProt: P22366) at a molecular weight of 33kDa.
Trusted by the scientific community
Anti-MyD88 [EPR21824] (ab219413) was first used in a scientific publication in 2018 and has been cited over 40 times in peer-reviewed journals.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Specificity confirmed
The specificity of Anti-MyD88 antibody [EPR21824] (ab219413) has been confirmed by Western blot testing in MYD88 Knockout HAP1 cells.
Other related products
We have a range of other formats of antibody clone [EPR21824] also available for your convenience: ab219413, Carrier free - ab236766
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MyD88 plays a significant role in mediating immune responses by forming part of a complex that includes IRAK kinases and TRAF6. When TLRs or IL-1Rs activate MyD88 this adaptor protein recruits IRAK4 which then phosphorylates IRAK1 or IRAK2. This cascade promotes the activation of NF-κB and MAPK pathways leading to the production of inflammatory cytokines. The MyD88-dependent pathway is integral to innate immunity influencing how the body responds to pathogen infection and inflammation.
Pathways
MyD88 integrates into both the TLR signaling and IL-1R signaling pathways. Key related proteins in these pathways include interleukin-1 receptor-associated kinase (IRAK) and tumor necrosis factor receptor-associated factor 6 (TRAF6). MyD88 initiates the recruitment and activation of IRAK1 and IRAK4 following receptor engagement leading to subsequent activation of downstream signals. As part of these pathways MyD88 mediates cellular responses important for immune system signaling and inflammatory response regulation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (76)
Recent publications for all applications. Explore the full list and refine your search
Drug design, development and therapy 19:6269-6282 PubMed40727923
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular medicine 56: PubMed40709387
2025
Applications
Unspecified application
Species
Unspecified reactive species
Inflammation : PubMed40601171
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Korean journal of pain 38:292-307 PubMed40556327
2025
Applications
Unspecified application
Species
Unspecified reactive species
Diabetology & metabolic syndrome 17:182 PubMed40448159
2025
Applications
Unspecified application
Species
Unspecified reactive species
European journal of trauma and emergency surgery : official publication of the European Trauma Society 51:178 PubMed40253667
2025
Applications
Unspecified application
Species
Unspecified reactive species
iScience 27:111488 PubMed39759009
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of biochemical and molecular toxicology 38:e70035 PubMed39552449
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in veterinary science 11:1431110 PubMed39329065
2024
Applications
Unspecified application
Species
Unspecified reactive species
Chemical biology & drug design 104:e14579 PubMed39013775
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com